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Thyroid hormones (THs) act on cells of 
almost all tissues and therefore are involved 
in several physiologic processes during a life 
span. In adults, THs are mainly involved in 
metabolic activities such as protein, lipid, and 
carbohydrate metabolism and heat genera-
tion (Kim 2008). They are also necessary for 
normal reproductive functions, regulation of 
heart rate, and gastro  intestinal motility, as well 
as for emotional stability (Bauer et al. 2008; 
Braverman and Utiger 2005). Disruptions of 
thyroid function by endogenous (e.g., auto-
antibodies) or exogenous (e.g., iodine) factors 
may produce various sub  clinical effects (Surks 
et al. 2004) or direct clinical manifestations. 
Consequently, there are concerns regarding 
the ubiquitous background chronic exposure 
of human populations to polyhalogenated 
compounds (PHCs), a group of chemicals 
that include legacy and emerging persistent 
organic pollutants that have been shown or 
are suspected to have thyroid-disrupting prop-
erties (Brouwer et al. 1995; Chang et al. 2008; 
Cheek et al. 1999; Hallgren et al. 2001; Kato 
et al. 2000; van Raaij et al. 1993).
Several epidemiologic studies aimed to 
evaluate the effects of dioxin-like compounds 
(DLCs), polychlorinated biphenyls (PCBs), 
and some organochlorine pesticides (OCPs) 
on TH homeostasis in adults (Abdelouahab 
et al. 2008; Hagmar 2003). Effects of these 
compounds on TSH concentrations were 
variable, whereas several studies found a nega-
tive relationship with total thyroxine (tT4) 
and/or total triiodo  thyronine (tT3), without 
a significant change on free thyroxine (fT4) 
levels. The relationship between hydroxylated 
metabolites of PCBs (HO-PCBs) and TH 
status in adults was studied only in fishermen 
from the Baltic Sea, and no association was 
found (Hagmar et al. 2001a). With regard 
to polybrominated diphenyl ethers (PBDEs), 
studies investigating the thyroid-disrupting 
potential of these flame retardants in popula-
tions exposed to background levels are scarce, 
inconsistent, and limited to male populations 
(Bloom et al. 2008; Hagmar et al. 2001a; 
Julander et al. 2005; Turyk et al. 2008). On 
the other hand, potential effects of perfluoro-
octane  sulfonate (PFOS) on THs in an envi-
ronmentally exposed adult population have 
been investigated only in one small study in 
which no significant association was observed 
with either TSH or fT4 (Bloom et al. 2009).
Nunavik Inuit are exposed to relatively 
high concentrations of PCBs and other organo-
chlorines (OCs) through their seafood-based 
traditional diet compared with populations 
from southern regions of North America. 
Considering the thyroid-disrupting potential 
of these contaminants, the aim of the pres-
ent study was to investigate the relationship 
between several PHCs and thyroid function in 
the Inuit adult population of Nunavik.
Materials and Methods
Population, study design, and data collection. 
We conducted a comprehensive health cross-
sectional study in the Inuit population of 
Nunavik (Québec, Canada) from 27 August 
to 1 October 2004. The target population 
of this study was permanent Inuit residents 
of Nunavik ≥ 18 years of age. We used a 
stratified random sampling of private Inuit 
households, with the community being the 
stratification variable. The study was approved 
by the Comité d’éthique de la recherche de 
l’Université Laval and the Comité d’éthique 
de santé publique du Québec. All participants 
provided written consent before taking part 
in the study.
Several self-administered and interviewer-
completed questionnaires were used to obtain 
information regarding demographics, lifestyle 
habits, and nutrition. In addition, individuals 
were asked to participate in a clinical session 
where blood samples were taken and physi-
cal measurements were performed. Overall, 
the participation rate for the different collec-
tion instruments was approximately 50%, 
for a total of 1,056 participants. We assessed 
contaminant concentrations on 889 plasma 
samples. Because TH concentrations fluctu-
ate greatly during pregnancy, we excluded 
pregnant women from the present study 
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Ba c k g r o u n d: Several ubiquitous polyhalogenated compounds (PHCs) have been shown to alter 
thyroid function in animal and in vitro studies. So far, epidemiologic studies have focused on the 
potential effect of a small number of them, namely, polychlorinated biphenyls (PCBs) and some 
organochlorines (OCs), without paying attention to other important PHCs. 
oBjectives: We investigated the relationship between exposure to several PHCs and thyroid hormone 
homeostasis in Inuit adults from Nunavik.
Me t h o d s : We measured thyroid parameters [thyroid-stimulating-hormone (TSH), free thyroxine 
(fT4), total triiodothyronine (tT3), and thyroxine-binding globulin (TBG)] and concentrations of 
41 contaminants, including PCBs and their metabolites, organochlorine pesticides (OCPs), poly-
brominated diphenyl ethers (PBDEs), perfluorooctanesulfonate (PFOS), and a measure of dioxin-
like compounds, detected in plasma samples from Inuit adults (n = 623).
re s u l t s: We found negative associations between tT3 concentrations and levels of 14 PCBs, 
7 hydroxylated PCBs (HO-PCBs), all methylsulfonyl metabolites of PCBs (MeSO2-PCBs), and 
2 OCPs. Moreover, we found negative associations between fT4 levels and hexachlorobenzene 
concentrations. TBG concentrations were inversely related to 8 PCBs, 5 HO-PCBs, and 3 OCPs. 
Exposure to BDE-47 was positively related to tT3, whereas PFOS concentrations were negatively 
associated with TSH, tT3, and TBG and positively with fT4 concentrations.
co n c l u s i o n: Exposure to several PHCs was associated with modifications of the thyroid parameters 
in adult Inuit, mainly by reducing tT3 and TBG circulating concentrations. The effects of PFOS 
and BDE-47 on thyroid homeostasis require further investigation because other human populations 
display similar or higher concentrations of these chemicals.
key w o r d s : dioxin-like compounds, hydroxylated metabolites, Inuit, organochlorines, perfluoro-
octane  sulfonate, polybrominated diphenyl ethers, polychlorinated biphenyls, polyhalogenated 
compounds, thyroid hormones. Environ Health Perspect 117:1380–1386 (2009).  doi:10.1289/
ehp.0900633 available via http://dx.doi.org/ [Online 12 May 2009]Environmental contaminants and thyroid hormone status
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(n = 23). Non-Inuit (n = 20) and individuals 
using medication for thyroid diseases (n = 19) 
were also excluded.
Demographic, clinical, and nutritional 
variables. We obtained data related to edu-
cation, income, and cigarette consumption 
through an interviewer-adminis  tered ques-
tionnaire; information on alcohol consump-
tion was obtained from a questionnaire 
completed confidentially by the participant. 
We obtained data regarding medication use 
in the 6 months preceding the study from 
medi  cal charts. Among participants with 
quantified concentrations of contaminants, 
729 had completed questionnaires regarding 
socio  demographic information, and 628 had 
records of medication consumption. Data on 
fish consumption were obtained using a food 
frequency questionnaire from 536 participants 
with quantified PHC concentrations. Details 
regarding the calculation of fish consumption 
are described in Supplemental Material avail-
able online (doi:10.1289/ehp.0900633.S1 via 
http://dx.doi.org/).
Laboratory procedures. Blood samples 
(60 mL) were collected using a venous cathe-
ter from an ante  cubital vein. Tubes were cen-
trifuged within 3 hr of collection and plasma 
was isolated, aliquoted, and frozen at –80°C 
before clinical bio  chemis  try and contami-
nant analyses. We analyzed plasma samples 
for PCBs and their hydroxylated (HO) 
and methyl  sulfonyl (MeSO2) metabolites, 
OCPs, halogenated phenolic compounds, 
and PBDEs according to a multi  residue gas 
chromatography/mass spectrometry (MS) 
method. Plasma samples were also analyzed 
for PFOS using liquid chromatography/MS 
and for DLCs using a reporter gene bioassay. 
See the Supplemental Material (doi:10.1289/
ehp.0900633.S1) for details of these labora-
tory procedures.
We report plasma concentrations of PCBs, 
PBDEs OCPs, and DLCs on a lipid basis. 
Cholesterol and triglyceride analyses were 
conducted using a Hitachi 917 auto ana-
lyzer and reagents from Roche Diagnostics 
(Indianapolis, IN, USA). Concentrations of 
total plasma lipids were estimated from cho-
lesterol and tri  glyceride levels according to the 
formula developed by Phillips et al. (1989).
We determined selenium concentrations 
in whole blood by inductively coupled plasma 
MS. Samples were diluted in ammonium 
hydroxide and then analyzed on an Elan 6000 
instrument (Perkin Elmer-Sciex, Ontario, 
Canada). The limit of detection (LOD) was 
0.09 µmol/L, and the coefficient of varia-
tion (CV) was 7.9% for a reference specimen 
(3.3 µmol/L) analyzed on 10 different days.
Analyses of serum thyroid-stimulating hor-
mone (TSH), fT4, tT3, and thyroxine-binding 
globulin (TBG; the major transport protein of 
TH), were performed using radio  immuno  assay 
methods. We meas  ured TSH, fT4, and tT3 
on the Elecsys 1010/2010 analyzers and the 
Modular Analytics E170 immunoassay mod-
ule (Roche Diagnostics). The inter  assay CVs 
were 2.0% for TSH, 4.7% for fT4, and 3.3% 
for tT3. TBG, determined using the Clinical 
Assays GammaDab system commercialized by 
DiaSorin (Stillwater, MN, USA), had an inter-
assay CV of 3.6%.
Statistical analysis. We determined poten-
tial effects of contaminants on thyroid status 
for PHCs with a detection frequency > 70%, 
except for BDE-47, which was detected in 57% 
of samples. We included BDE-47 regardless of 
detection frequency because of the growing 
concern regarding the rapid increase in concen-
trations meas  ured in human samples in North 
America and because of its toxicologic proper-
ties. Parameters were estimated randomly from 
a log-normal distribution using the maximum 
likelihood estimation for samples with concen-
trations of contaminants below LODs of the 
analytical procedures. The multiple imputation 
method was an adequate statistical approach 
compared with the assignment of a value equal 
to LOD/2 when non  detected values represent 
> 5% of the sample (Lubin et al. 2004). Effects 
of PCB congeners were assessed individually 
or as a group for mono-ortho PCBs (PCBs 74, 
105, 118, and 156). We examined the relation-
ship of environmental contaminants with THs 
(TSH, fT4, and tT3) and TBG by simple and 
multiple linear regression models. Contaminant 
concentrations and thyroid parameters were all 
log-transformed to satisfy criteria of normality. 
Five participants with extreme values of TSH 
were excluded.
Interaction terms between sex and all con-
taminants in relation to TH concentrations 
were tested in full models. Because all inter-
action terms were non  significant, we exam-
ined effects of PHCs on the TH homeo  stasis 
in men and women jointly. We tested covari-
ates known as risk factors for thyroid diseases 
or suspected to be associated with TH param-
eters to determine if they should be included 
in regression models. Covariates associated 
at a p-value ≤ 0.10 were included in multiple 
regression models to assess their confound-
ing influence. Covariates are presented in 
Table 1 and are expressed as continuous vari-
ables, except where noted. Some participants 
declared taking medi  cation known to alter 
thyroid function tests, including estrogen for-
mulations, heparin, beta-blockers, furosemide, 
nonsteroidal anti-inflammatory agents, gluco-
corticoids, anti  convulsants, dopaminergics, 
and carboxamides. We created a dichotomous 
Table 1. Characteristics of adult Inuit of Nunavik.
Characteristic No. Percentage Mean ± SD Range
Sex (%)
  Male 245 39.3
  Female 378 60.7
Menopause (% among females)
  Yes  52 12.5
  No 363 87.5
Age (years) 623 36.8 ± 13.9 18–73
Body mass index (kg/m2) 623 27.4 ± 5.7 17.2–48
Selenium (µmol/L) 622 4.4 ± 3.0 1.5–30.0
No. of cigarettes/day (%)
 0 136 21.8
  1–10 187 30.0
  11–24 226 36.3
  ≥ 25  74 11.9
Frequency of alcohol consumption (%)
  Never or yearly 287 49.4
  Monthly 148 25.8
  Weekly 101 17.4
  Daily 45 7.8
Fish consumption (g/day)a 563 54.7 ± 75.1 0–665.6
Marine mammal consumption (g/day)a 561 27.1 ± 44.4 0–398.7
Education (%)
  None 46 7.4
  Elementary school 99 15.9
  High school 394 63.2
  University  84 13.5
TSH (mIU/L)b 623 1.18 ± 0.79 0.06–6.45
fT4 (pmol/L)b 621 15.5 ± 2.1 9.3–22.9
tT3 (nmol/L)b 621 2.14 ± 0.33 1.21–3.39
TBG (µg/mL)b 622 24.0 ± 6.0 8.0–62.8
Medication use in the last 6 months (%)
  Yes  106 17.0
  No 517 83.0
aExpressed on an annual basis. bLaboratory euthyroid reference range: TSH, 0.27–4.20 mIU/L; fT4, 12–22 pmol/L; tT3, 
1.3–3.1 nmol/L; TBG, 13–30 µg/mL.Dallaire et al.
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variable to account for the consumption of 
those medications. Covariates that modified 
the regression coefficient of the contaminants 
with any of the THs by > 10% were included 
in adjusted models. However, considering 
that data concerning alcohol and fish con-
sumption were missing for 42 and 92 partici-
pants, respectively, and that their confounding 
effects were observed for a small proportion 
of associations, their inclusion in regression 
models was not systematic. We evaluated 
multi  collinearity for all multiple regression 
models. Also, a contaminant in each family of 
PHCs (PCB-153, BDE-47, and PFOS) was 
selected and introduced together in multiple 
models to assess their influence on the associa-
tions with the contaminants under study.
We used sample weights to account for 
the complex sampling method and to obtain 
appropriate SEs and p-values. We considered a 
bilateral p-value < 0.05 statistically significant. 
Statistical analyses were performed with SAS 
(version 9.1; SAS Institute Inc., Cary, NC, 
USA) and SUDAAN software (version 9.0.1; 
Research Triangle Institute, Research Triangle 
Park, NC, USA).
Results
Sociodemographic, personal, and clinical 
characteristics of participants are presented 
in Table 1. Most participants had TH con-
centrations in the laboratory test euthyroid 
range (TSH, 95.0%; fT4, 96.5%; tT3, 99.2%; 
TBG, 86.3%). Plasma concentrations of 
PHCs measured in adult Inuit are shown in 
Table 2. Concentrations of all PCB conge-
ners were highly inter  correlated (r = 0.71–
0.98; p < 0.001) and were strongly correlated 
with their metabolites [for the sum of PCBs 
(ΣPCBs) and ΣHO-PCBs, r = 0.94; for ΣPCBs 
and ΣMeSO2-PCBs, r = 0.90; p < 0.001]. 
ΣPCB was less strongly correlated with DLC 
concentration (r = 0.69; p < 0.001) but still 
highly correlated with concentrations of OCPs 
(r = 0.85–0.95; p < 0.001). Pentachlorophenol 
was not correlated with any contaminant. 
Plasma concentrations of BDE-47 were 
moderately correlated with BDE-153 levels 
(r = 0.36; p < 0.001) but were not correlated 
with those of other contaminants. Plasma con-
centrations of PFOS were moderately corre-
lated with those of PCB congeners and their 
metabolites (r = 0.47–0.55; p < 0.001), other 
OCs (r = 0.36–0.51; p < 0.001), and BDE-153 
(r = 0.22; p < 0.001) but not with BDE-47.
Associations between contaminant plasma 
concentrations and TH concentrations are pre-
sented in Tables 3–5. Associations with further 
adjustment for exposure to other families of 
contaminants are presented in Supplemental 
Material, Tables S1–S3 (doi:10.1289/
ehp.0900633.S1). We observed significant 
negative associations between the more highly 
chlorinated PCB congeners and TSH in mul-
tiple linear regression models (Table 3). We 
found no association between concentrations 
of PCB congeners or their groupings and 
fT4 levels in adjusted models. Fourteen PCB 
congeners, ΣPCBs, and the mono-ortho PCB 
group, as well as the DLCs, were negatively 
associated with tT3 concentrations in multiple 
models. Further adjustment for fish consump-
tion weakened associations with some PCB 
congeners and groupings. We observed sig-
nificant negative associations between TBG 
concentrations and less-chlorinated PCBs as 
well as the mono-ortho PCB group grouping in 
adjusted models. The significance of some asso-
ciations disappeared after controlling for fish 
and alcohol consumption. Also, adjustment for 
other families of contaminants weakened some 
associations with TSH, tT3, and TBG while 
revealing significant negative associations of 
PCB-118 and mono-ortho PCB congeners with 
fT4 concentrations [Supplemental Material, 
Table S1 (doi:10.1289/ehp.0900633.S1)].
HO-PCBs and MeSO2-PCBs were not 
significantly associated with TSH and fT4 
Table 2. Plasma concentrations of PHCs in Inuit participants.
Analyte No. Percent detected Geometric mean 95% CI Range
PCB congenera
  PCB-74 623 95.0 8.92 8.15–9.75 < LOD–218.77
  PCB-99 623 99.7 25.53 23.38–27.87 < LOD–849.53
  PCB-105 623 78.4 3.49 3.10–3.93 < LOD–100.74
  PCB-118 623 99.8 22.76 20.79–24.91 < LOD–497.09
  PCB-138 623 100 78.03 71.41–85.26 3.66–1388.42
  PCB-146 623 98.7 22.15 20.14–24.36 < LOD–589.00
  PCB-153 623 100 180.06 163.71–198.06 5.69–5805.15
  PCB-156 623 87.7 6.70 5.97–7.51 < LOD–330.97
  PCB-163 623 99.2 26.88 24.39–29.63 < LOD–807.77
  PCB-170 623 99.4 25.88 23.42–28.61 < LOD–869.17
  PCB-172 621 78.7 3.95 3.49–4.47 < LOD–180.20
  PCB-177 623 82.7 3.96 3.56–4.41 < LOD–89.13
  PCB-178 623 90.1 7.83 7.01–8.73 < LOD–235.60
  PCB-180 623 100 93.28 84.53–102.93 3.25–3510.34
  PCB-183 623 93.5 9.16 8.35–10.06 < LOD–177.74
  PCB-187 623 99.8 37.98 34.67–41.61 1.18–790.66
  PCB-194 623 95.1 15.74 13.94–17.77 < LOD–945.49
  PCB-201 623 96.1 15.88 14.19–17.78 < LOD–772.27
  PCB-203 623 89.4 7.93 7.08–8.88 < LOD–294.20
  PCB-206 623 78.2 4.02 3.51–4.59 < LOD–275.81
PCB groupinga
  ΣPCBs 621 635.98 579.33–698.18 31.47–14260.92
  Mono-ortho PCB 623 45.24 41.34–49.51 1.80–866.67
  DLCsb 607 72.6 10.62 10.04–11.23 < LOD–139.30
HO-PCBc
  3-HO-PCB-138 562 89.0 30.38 27.17–33.98 < LOD–980
  3-HO-PCB-153 536 97.5 36.27 32.38–40.63 < LOD–1,500
  4-HO-PCB-107 566 99.5 173.21 158.67–189.08 < LOD–3,200
  4-HO-PCB-146 536 99.5 136.88 123.26–152.01 < LOD–4,900
  4-HO-PCB-163 567 94.0 11.20 10.20–12.29 < LOD–590
  4-HO-PCB-172 550 96.6 19.19 17.30–21.27 < LOD–790
  4-HO-PCB-187 567 99.8 157.69 143.67–173.07 < LOD–4,300
  4-HO-PCB-199 568 94.5 19.10 17.20–21.22 < LOD–1,200
  4-HO-PCB-202 566 87.9 8.42 7.66–9.26 < LOD–340
  4-HO-PCB-208 568 75.0 5.64 5.13–6.21 < LOD–340
  ΣHO-PCBs 536 642.02 584.52–705.18 39.44–14,610
MeSO2-PCBc
  3-MeSO2-PCB-49 573 93.4 26.39 23.77–29.30 < LOD–910
  3-MeSO2-PCB-87 573 76.5 11.23 10.04–12.57 < LOD–610
  3-MeSO2-PCB-101 575 86.9 18.50 16.55–20.68 < LOD–920
  ΣMeSO2-PCBs 573 57.54 51.71–64.03 < LOD–2,270
OCa
  p,p´-DDE 623 100 477.78 441.70–516.81 12.85–8306.48
  HCB 623 99.7 61.36 56.38–66.78 < LOD–1245.97
  Pentachlorophenolc 567 100 801.43 758.25–847.07 140–18,000
  β-HCH 622 95.9 8.33 7.70–9.02 < LOD–201.94
PBDEa
  BDE-47 623 57.3 2.16 1.84–2.54 < LOD–343.45
  BDE-153 623 73.8 2.05 1.85–2.27 < LOD–75.74
Perfluorinated compound
  PFOSc 621 100 18,280 17,190–19,440 480–470,000
Abbreviations: β-HCH, β-hexachlorocyclohexane; DDE, p,p´-dichlorodiphenyldichloroethylene; HCB, hexa  chloro  benzene.
aLipid standardized concentrations (µg/kg). bConcentrations in picograms toxic equivalents per gram lipids. cConcentrations 
on a wet weight basis (ng/L).Environmental contaminants and thyroid hormone status
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concentrations in multiple models, except 
for HO-PCB-199 and HO-PCB-208, which 
were negatively related to TSH (Table 4). 
Seven HO-PCBs, the ΣHO-PCBs, three 
MeSO2-PCBs, and the ΣMeSO2-PCBs were 
all significantly associated with a decrease 
in tT3 concentrations. We also found sig-
nificant negative associations between TBG 
and five HO-PCBs and the ΣHO-PCBs. 
Only the associations for HO-PCB-107 and 
ΣHO-PCBs remained significant after con-
trolling for fish consumption. Control for 
the exposure to other families of contami-
nants weakened some associations with tT3 
and TBG but revealed significant negative 
associations of all MeSO2-PCBs metabo-
lites and their sum (ΣMeSO2-PCBs) with 
fT4 levels [Supplemental Material, Table S2 
(doi:10.1289/ehp.0900633.S1)].
Plasma concentrations of OCPs were 
not significantly associated with TSH levels 
(Table 5). Also, among OCPs, only hexa-
chloro  benzene (HCB) concentrations were 
negatively associated with fT4 circulat-
ing levels, whereas this compound and 
β-hexachlorocyclohexane (β-HCH) were neg-
atively related to tT3 concentrations. TBG 
concentrations were negatively associated 
with all OCPs, except for pentachloro  phenol 
in multiple models. Further adjustments 
for alcohol consumption had no impact on 
the relationship between OCPs and TH 
parameters, except for TBG, for which only 
the associations with HCB and β-HCH 
remained significant. Adjustment for other 
families of contaminants revealed a signifi-
cant positive association between β-HCH 
and TSH levels [see Supplemental Material, 
Table S3 (doi:10.1289/ehp.0900633.S1)]. 
Pentachlorophenol plasma concentrations were 
not associated with any of the TH parameters. 
Among PBDEs, only BDE-47 was positively 
associated with tT3 concentrations in multiple 
models. This association weakened after con-
trolling for fish consumption. We observed 
a significant negative association for PFOS 
concentrations with TSH, tT3, and TBG cir-
culating levels, whereas we found a positive 
association with fT4 levels. Adjustment for 
other potential confounders and families of 
contaminants weakened the association with 
tT3 concentrations.
Discussion
Our findings in the present study suggest 
modifications of the thyroid parameters in 
adult Inuit by PHCs. This is the first large-
scale study investigating the effect of PFOS 
on TH homeo  stasis in an environmentally 
exposed adult population. We observed sig-
nificant negative associations of PFOS con-
centrations with TSH, tT3, and TBG levels, 
whereas we found a positive association with 
fT4 concentrations. Furthermore, although 
exposure to BDE-47 in Inuit adults is lower 
than that in other North American popu-
lations, we found a positive association of 
tT3 with increasing concentrations BDE-47. 
Several PCBs, their metabolites, and OCPs 
are negatively associated with tT3.
Thyroid parameters in Inuit adults were 
mostly affected by exposure to PFOS. Indeed, 
we found a negative association of PFOS con-
centrations with circulating TSH, tT3, and 
TBG levels and a positive relationship with 
fT4. Toxicologic studies dedicated to inves-
tigating the thyroid-disrupting properties of 
PFOS are rare and focus mainly on mater-
nal and fetal thyroid functions. In adult rats, 
PFOS was shown to compete with fT4 for 
transport proteins (Chang et al. 2008), leading 
to a transient increase in fT4 and decrease in 
TSH concentrations. However, these authors 
also found a non  transient reduction in tT4 and 
tT3, with the latter being less affected. These 
results in laboratory animals are consistent with 
perturbations we observed on the TH homeo-
stasis in Inuit, except that effects observed on 
the circulating concentrations of fT4 and TSH 
do not seem to be transient in our study.
Although exposure to PBDEs in Inuit men 
and women is lower than levels reported in 
other North American populations, we found 
a positive association of tT3 with BDE-47 but 
no association with BDE-153. These results 
differ from those observed in men from other 
fish-eating communities. Exposure to PBDEs 
was positively related to tT4, fT4, and urinary 
T4, as well as with reverse T3 levels, and nega-
tively related to tT3 and TSH in Great Lake 
fish consumers (Turyk et al. 2008). In addi-
tion, fT4 and TSH were not associated with 
Table 3. Linear regression models of THs and TBG plasma levels with PCB and DLC concentrations (wet weight basis).
TSH fT4 T3 TBG
Analyte No. Unadjusted β Adjusted β Unadjusted β Adjusted β Unadjusted β Adjusted β Unadjusted β Adjusted β
PCB congener
  PCB-74 623 0.052** 0.014 –0.019# –0.004 –0.028# –0.020* –0.001 –0.036#
  PCB-99 623 0.054** 0.022 –0.015** 0.003 –0.025# –0.012 –0.004 –0.034**
  PCB-105 623 0.039** 0.017 –0.015# –0.004 –0.021# –0.018** –0.001 –0.030#
  PCB-118 623 0.058** 0.027 –0.021# –0.009 –0.030# –0.028** –0.005 –0.051#
  PCB-138 623 0.046* 0.000 –0.016# 0.000 –0.027# –0.015 –0.001 –0.028*
  PCB-146 623 0.035* –0.023 –0.016# –0.004 –0.028# –0.020** –0.000 –0.026*a
  PCB-153 623 0.033 –0.024 –0.014** 0.001 –0.027# –0.017*a 0.001 –0.021
  PCB-156 623 0.021 –0.035 –0.012** –0.003 –0.022# –0.014*a 0.005 –0.003
  PCB-163 623 0.039* –0.009 –0.016# –0.007 –0.028# –0.023** 0.000 –0.024*a
  PCB-170 623 0.026 –0.040 –0.014# –0.004 –0.026# –0.016*a 0.007 –0.000
  PCB-172 621 0.025 –0.019 –0.010** 0.000 –0.022# –0.014* 0.004 –0.005
  PCB-177 623 0.036* –0.006 –0.014** –0.002 –0.024# –0.015* 0.001 –0.018*b
  PCB-178 623 0.021 –0.039 –0.014** –0.007 –0.025# –0.019** 0.003 –0.008
  PCB-180 623 0.020 –0.059* –0.012** 0.001 –0.025# –0.011 0.007 –0.000
  PCB-183 623 0.031 –0.024 –0.012** 0.006 –0.025# –0.011 0.003 –0.017
  PCB-187 623 0.040* –0.013 –0.017# –0.006 –0.029# –0.018*a 0.001 –0.023
  PCB-194 623 0.008 –0.069** –0.011** –0.003 –0.021# –0.012*c 0.007 0.005
  PCB-201 623 0.016 –0.051* –0.012** –0.003 –0.024# –0.016*a 0.006 –0.003
  PCB-203 623 0.008 –0.069** –0.010** 0.003 –0.021# –0.008 0.006 –0.000
  PCB-206 623 0.001 –0.075** –0.009** 0.004 –0.017# –0.003 0.011 0.013
PCB grouping
  ΣPCBs 623 0.029 –0.040 –0.015# –0.003 –0.029# –0.020* 0.003 –0.017
  Mono-ortho PCBs 623 0.051** 0.009 –0.021# –0.012 –0.031# –0.028# 0.001 –0.037**
  DLCs 607 0.092# 0.019 –0.017* 0.007 –0.043# –0.027* –0.002 –0.027
All models adjusted for sex, age, body mass index, plasma lipids, cigarette consumption (cigarettes/day), and education. Associations remained significant after adjusting for fish and 
alcohol consumption, unless noted.
aBorderline significant after adjusting for fish consumption (0.05 < p < 0.07). bNot significant after adjusting for alcohol consumption. cNot significant after adjusting for fish consumption. 
*p ≤ 0.05. **p < 0.01. #p < 0.001.Dallaire et al.
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PBDEs in New York sport fish consumers 
(Bloom et al. 2008), whereas a negative asso-
ciation with TSH, but not fT4, was reported 
in anglers from the Baltic Sea (Hagmar et al. 
2001a). No other epidemiologic study assessed 
the potential effect of PBDEs on women’s 
thyroid function. So far, associations observed 
in human studies are not consistent with 
effects observed in animal models. Exposure 
to PBDE commercial mixtures was systemati-
cally associated with decreased T4 concentra-
tions, subtle variations of T3, and unchanged 
TSH concentrations in rodents (Hallgren et al. 
2001; Zhou et al. 2001).
We observed similar associations between 
thyroid function parameters and concentra-
tions of PCB congeners, their metabolites, 
and concentrations of OCPs and DLCs. This 
is not surprising because the Inuit population 
is exposed to a complex mixture of OCs, with 
concentrations of compounds being highly 
inter  correlated. Consequently, it is almost 
impossible to isolate specific effects of PCB 
congeners and their metabolites, as well as 
OCPs, on the thyroid system in the context 
of epidemiologic studies in this population. 
TSH concentrations were lowered only by 
exposure to the most chlorinated PCB conge-
ners and HO metabolites. Total T3 concen-
trations were negatively associated with almost 
all PCB congeners and their metabolites, as 
well as with OCPs and DLCs. Circulating 
levels of TBG, the predominant TH carrier 
protein in humans, were negatively associated 
with the less chlorinated PCBs, all HO-PCBs, 
and almost all other OCPs. Adjustment for 
other families of contaminants weakened 
some associations of PCB congeners and their 
metabolites as well as OCPs with TH param-
eters, probably because introduction of con-
taminants in regression models that were not 
associated with TH parameters added random 
variation in statistical models.
Most epidemiologic studies examining the 
relations between PCBs and thyroid function 
in adults reported no association with TSH 
and fT4 (Hagmar et al. 2001a, 2001b; Meeker 
et al. 2006; Rylander et al. 2006; Sala et al. 
2001). Associations with tT4 and/or tT3 were 
reported to be negative in half of the studies, 
whereas the remaining studies found no rela-
tion with these hormones (Abdelouahab et al. 
2008). Interestingly, associations of PCBs with 
total T3 and T4 were never positive. Therefore, 
results from the present study are in accor-
dance with most previous findings in human 
adults. The independent effect of PCB expo-
sure on tT3 circulating levels was previously 
reported in American men from the general 
population of Boston, Massachusetts (Meeker 
et al. 2006), in obese men that underwent a 
weight-loss program (Pelletier et al. 2002), 
and in fishermen’s wives who consumed 
PCB-contaminated fish from the Baltic Sea 
(Hagmar et al. 2001b). Although the thyroid 
function of pregnant women and children 
may not be comparable because they may be 
more vulnerable to thyroid dysfunction, iso-
lated effects on T3 concentrations have also 
been observed in pregnant Canadian women 
(Takser et al. 2005), as well as in children 
from Germany and Spain (Alvarez-Pedrerol 
et al. 2008; Osius et al. 1999).
Toxicologic studies with animal models 
have demonstrated differential mechanisms by 
Table 4. Linear regression models of THs and TBG plasma levels with HO-PCB and MeSO2-PCB concentrations (wet weight basis).
TSH fT4 T3 TBG
Analyte No. Unadjusted β Adjusted β Unadjusted β Adjusted β Unadjusted β Adjusted β Unadjusted β Adjusted β
HO compound
  3-HO-PCB-138 562 0.033* –0.009 –0.014** –0.003 –0.031# –0.027# –0.002 –0.021*a
  3-HO-PCB-153 536 0.029 –0.017 –0.009 0.008 –0.028# –0.023** –0.001 –0.027*b
  4-HO-PCB-107 566 0.020 –0.020 –0.011* 0.009 –0.029# –0.013 –0.016 –0.052#
  4-HO-PCB-146 536 0.025 –0.025 –0.014** –0.003 –0.028# –0.018*b 0.000 –0.023*b
  4-HO-PCB-163 567 0.023 –0.052 –0.015** –0.002 –0.032# –0.020* –0.004 –0.023
  4-HO-PCB-172 550 0.027 –0.028 –0.012* 0.002 –0.031# –0.024** –0.001 –0.021
  4-HO-PCB-187 567 0.023 –0.052 –0.014* –0.000 –0.033# –0.022* –0.006 –0.029*b
  4-HO-PCB-199 568 0.008 –0.084** –0.010* 0.003 –0.027# –0.014 0.001 –0.008
  4-HO-PCB-202 566 0.019 –0.056 –0.013* –0.001 –0.033# –0.023** –0.001 –0.016
  4-HO-PCB-208 568 0.006 –0.084* –0.011* 0.002 –0.027# –0.011 0.003 –0.007
  ΣHO-PCBs 536 0.035 –0.025 –0.015* 0.000 –0.033# –0.025* –0.002 –0.034**
MeSO2-PCB
  3-MeSO2-PCB-49 573 0.040* –0.007 –0.018# –0.008 –0.028# –0.019** 0.003 –0.011
  3-MeSO2-PCB-87 573 0.040* 0.002 –0.018# –0.010 –0.026# –0.017** 0.003 –0.011
  3-MeSO2-PCB-101 575 0.037* –0.009 –0.017# –0.008 –0.026# –0.016* 0.006 –0.004
  ΣMeSO2-PCBs 573 0.041* –0.006 –0.018# –0.009 –0.028# –0.018** 0.005 –0.008
All models adjusted for sex, age, body mass index, plasma lipids, cigarette consumption (cigarettes/day), and education. Associations remained significant after adjusting for fish and 
alcohol consumption unless noted.
aNot significant after adjusting for fish consumption. bBorderline significant after adjusting for fish consumption (0.05 < p < 0.07). *p ≤ 0.05. **p < 0.01. #p < 0.001.
Table 5. Linear regression models of THs and TBG plasma levels with OCPs, PBDE, and PFOS concentrations (wet weight basis).
TSH fT4 T3 TBG
Analyte No. Unadjusted β Adjusted β Unadjusted β Adjusted β Unadjusted β Adjusted β Unadjusted β Adjusted β
OC
  p,p´-DDE 623 0.051* 0.012 –0.021# –0.007 –0.030# –0.016 –0.001 –0.030*a
  HCB 623 0.048* 0.010 –0.026# –0.017** –0.033# –0.030# –0.006 –0.054#
  Pentachlorophenol 567 0.008 –0.001 0.022** 0.014 –0.008 –0.009 –0.037* –0.021
  β-HCH 622 0.081# 0.047 –0.022# –0.008 –0.032# –0.028** –0.007 –0.051#
PBDE
  BDE-47 623 0.000 –0.002 0.002 0.001 0.010# 0.008**b 0.002 0.003
  BDE-153 623 0.017 –0.009 0.007 0.009  –0.001 0.005 –0.002 0.005
Perfluorinated compound
  PFOS 621 –0.017 –0.102* 0.004 0.014* –0.030# –0.017* –0.026* –0.034**
All models adjusted for sex, age, body mass index, plasma lipids, cigarette consumption (cigarettes/day), and education. Associations remain significant after adjusting for fish and alco-
hol consumption unless noted.
aBorderline significant after adjusting for alcohol consumption (0.05 < p < 0.07). bBorderline significant after adjusting for fish consumption (0.05 < p < 0.07). *p ≤ 0.05. **p < 0.01. 
#p < 0.001.Environmental contaminants and thyroid hormone status
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 9 | September 2009  1385
which PCBs and OCPs induce perturbations 
of the thyroid system, mainly by reducing fT4 
concentrations (Brouwer et al. 1995; Cheek 
et al. 1999; van Raaij et al. 1993). DLCs, 
including some PCB congeners, bind to the 
aryl hydro  carbon receptor (AhR) and activate 
the hepatic uridine diphosphate glucuronyl-
transferase (UDP-GT) enzymes responsible 
for T4 glucuronidation, resulting in T4 excre-
tion in bile. Non-DL-PCBs do not cause 
AhR-dependent effects but induce microsomal 
cytochrome P450 enzymes 2B and 3A that 
may also reduce circulating T4 levels (Khan 
et al. 2002). However, these mechanisms do 
not explain the selective effect of most PCBs 
and OCPs on tT3 concentrations observed in 
this study and others. One possible explana-
tion could be that some of the compounds 
may affect peripheral deiodination of T4 by 
inactivation of deiodinase enzymes (Schuur 
et al. 1998), leading to reduced T3 levels. Also, 
some PCBs or their metabolites may alter the 
activities (activation or inactivation) of specific 
T3- or T4-directed hepatic UDP-GT enzymes, 
affecting principally the circulating levels of 
T3 (Vansell and Klaassen 2002). However, 
we are unable to adequately evaluate those 
hypotheses because we did not measure tT4 
in the course of this study. Another potential 
mechanism could be that those compounds 
primarily affect TBG concentrations, leading 
to a reduction in the TH-binding capacity of 
serum. Because serum THs are mainly bound 
to carrier proteins and TBG is the main trans-
porter (75% T4 and 70% T3) (Schussler 
2000), such alterations could reduce total TH 
concentrations as we observed with tT3 in this 
study. Interestingly, individuals with inherited 
or acquired TBG excess have elevated total T3 
and T4 concentrations, whereas those with 
TBG deficiency have decreased concentrations 
(Bartalena and Robbins 1992). Nevertheless, 
those individuals are still considered euthyroid 
because of their normal TSH and fT4 levels. 
Similarly, PCBs or OCPs may affect TBG 
levels and consequently tT3 and tT4 without 
modifying TSH and fT4 concentrations. This 
potential mechanism could explain why most 
epidemiologic studies among adults reported 
negative associations with circulating tT4 and/
or tT3 but no association with TSH and fT4.
We could not compare our results on the 
effect of PCBs on TBG concentrations in 
adults because TBG quantification was not 
performed in other epidemiologic studies. 
Explanations given for the negative associa-
tions between several PHCs and TBG con-
centrations observed in two previous studies 
(Dallaire et al. 2008, 2009) and this one are 
unclear, but they suggest a decrease of TBG 
synthesis by the liver or an increase in catabo-
lism. Unfortunately, such mechanisms cannot 
be corroborated by toxicologic data because 
studies have focused on the competitive 
binding assessment of contaminants with T4, 
without paying attention to their possible 
ability to modify transport protein synthesis.
In the present study, exposure to HCB 
was associated with reduced fT4 concentra-
tions. Exposure to HCB was also related to a 
concomitant decline in tT3 and TBG, with-
out association with TSH concentrations. 
HCB-treated rats usually showed a decline in 
fT4 and tT4 levels with no change in tT3 and 
inconsistent effects on TSH concentrations 
(Alvarez et al. 2005; van Raaij et al. 1993). 
Activation of hepatic UDP-GT enzymes by 
HCB, followed by T4 glucuronidation and 
subsequent biliary excretion, is the main 
mechanism explaining hypothyroidism state 
in rats. In humans, considering our findings, 
this contaminant may induce a reduction in 
TBG concentrations, which decreases the T3 
and potentially T4 binding capacity of serum, 
whereas reduction of fT4 may be related to 
UDP-GT enzymes induction in the liver.
HO-PCBs and pentachlorophenol were 
not associated with a significant reduction in 
fT4 concentrations. Only one study has inves-
tigated the effect of HO-PCBs on thyroid 
homeostasis of fishermen consuming fish from 
the Baltic Sea, and no association was found 
(Hagmar et al. 2001a). Those compounds have 
been shown to be potent competitive inhibitors 
of T4 binding to trans  thyretin (van den Berg 
1990), one of the TH carrier proteins, leading 
to increased T4 metabolism. However, because 
trans  thyretin contributes to only one-fifth of 
bound T4, this mechanism is less likely to have 
an impact on fT4 concentrations in adults. On 
the other hand, such a mechanism could be 
important in fetuses and neonates because tran-
sthyretin is involved in T4 placental transfer 
(McKinnon et al. 2005) and transport through 
the blood–brain barrier (Schreiber et al. 1995).
Results from the present study demon-
strate that PHCs differentially alter the circu-
lating levels of THs in humans. It is therefore 
extremely difficult to predict the total effect 
of exposure to a complex mixture of thyroid- 
disrupting chemicals on thyroid status. 
Assessments of effects of exposure to mixtures 
on the thyroid systems in animal models are 
scarce. In male rats, additivity under  estimated 
the effect of a mixture of 16 OCs, lead, and 
cadmium on different thyroid end points 
(Wade et al. 2002). Relationship between 
tT4 and exposure to a mixture of dioxins, 
furans, and PCBs in rats was shown to be 
additive at the lowest doses, but synergism 
was observed at higher doses (Crofton et al. 
2005). From our results and those of oth-
ers, there is increasing evidence that emerg-
ing persistent chemicals such as PBDEs and 
PFOS are also thyroid disrupting and should 
be included in future studies aiming to assess 
the potential effects of persistent organic pol-
lutants on the thyroid system.
This study has several strengths that are 
worth mentioning. First, we used a sample-
based sampling design and recruited a large 
number of participants. We considered con-
founding effects for an important number of 
covariates, including medication use and con-
comitant exposure to other PHCs. However, 
we were unable to evaluate the individual effect 
of OCs on TH status by controlling for other 
OCs because of the high intercorrelations 
between these compounds. One limitation 
of this study is that we did not use the equi-
librium dialysis method that is less binding- 
protein dependent for fT4 quantification.
In summary, we observed a significant 
reduction of tT3 with exposure to several 
PCBs and their metabolites, as well as expo-
sure to some OCPs. A large number of PHCs 
seem to modify circulating levels of TBG, 
the main TH transport protein in humans. 
In addition, we found that exposure to 
BDE-47 and PFOS, at levels observed in sev-
eral populations worldwide, appear to modify 
levels of TH parameters. However, other epi-
demiologic, animal, and in vitro studies are 
needed to corroborate these results. Because 
most Inuit participants had a thyroid status 
within the euthyroid range, it is not clear if 
the observed effects could be associated with 
increasing disease burden in adults.
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